Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. BelgiŽ
  4. Euronext Bruxelles
  5. Mithra Pharmaceuticals S.A.
  6. Nieuws
  7. Persberichten
    MITRA   BE0974283153

MITHRA PHARMACEUTICALS S.A.

(MITRA)
Real-time koersen. Real Time Euronext Bruxelles - 17/09 17:35:14
20.35 EUR   --.--%
19/09Week in teken van Federal Reserve
AM
16/09Mithra krijgt Russische goedkeuring voor Estelle
AM
15/09Tweede afzetmarkt voor nieuwe anticonceptiepil Mithra
AM
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť MITHRA PHARMACEUTICALS S.A.
17/09MITHRA PHARMACEUTICALS S A : to Host Webcast for Half Year Financial Results on ..
PU
16/09MITHRA PHARMACEUTICALS S A : Announces Estelleģ Approval in Russia
PU
15/09MITHRA PHARMACEUTICALS S A : and Searchlight Pharma Announce Availability of Nex..
PU
13/08MITHRA PHARMACEUTICALS S A : extends the pricing period for the put option annou..
PU
15/07MITHRA PHARMACEUTICALS S A : ExeVir and Mithra announce manufacturing collaborat..
PU
05/07MITHRA PHARMACEUTICALS S A : Issues a Put Option Notice Under Capital Agreement ..
AQ
02/07MITHRA PHARMACEUTICALS S A : Issues a Put Option Notice Under Capital Agreement ..
PU
25/06MITHRA PHARMACEUTICALS S A : successfully renegotiates the earnouts relating to ..
AQ
24/06MITHRA PHARMACEUTICALS S A : successfully renegotiates the earnouts relating to ..
PU
22/06Estelle Oral Contraceptive Now Available In the United States
AQ
21/06MITHRA PHARMACEUTICALS : Estelleģ Oral Contraceptive Now Available In The United..
PU
28/05Mayne - Nextstellis Receives FDA Marketing Exclusivity And Phase III Data Pub..
AQ
27/05MAYNE PHARMA : Nextstellis receives fda marketing exclusivity and phase iii data..
AQ
27/05MITHRA PHARMACEUTICALS S A : Nextstellisģ Receives FDA Marketing Exclusivity and..
PU
21/05MITHRA PHARMACEUTICALS S A : Announces European Approval of Estelle
AQ
20/05MITHRA PHARMACEUTICALS S A : Announces European Approval of Estelleģ
PU
28/04MITHRA PHARMACEUTICALS S A : takes note of François Fornieri's indictment
PU
21/04MITHRA PHARMACEUTICALS S A : Releases 2020 Annual Report and Invitation to its S..
AQ
20/04MITHRA PHARMACEUTICALS S A : Releases 2020 Annual Report and Invitation to its S..
PU
16/04MITHRA PHARMACEUTICALS S A : Transparency Notification from Alychlo NV
PU
16/04MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received..
PU
16/04MAYNE PHARMA : And mithra announce fda approval of new oral contraceptive nextst..
AQ
16/04Mayne Pharma and Mithra Announce FDA Approval of New Oral Contraceptive Estel..
AQ
29/03Richter and Mithra Receive Positive CHMP Opinion for Estelle
AQ
26/03MITHRA PHARMACEUTICALS S A : Richter and Mithra Receive Positive CHMP Opinion fo..
PU
10/03MITHRA PHARMACEUTICALS S A : Reports Full Year 2020 Financial Results
AQ
08/03MITHRA PHARMACEUTICALS S A : and Searchlight Pharma Announce Nextstellisģ Approv..
AQ
05/03MITHRA PHARMACEUTICALS S A : to Host Webcast for 2020 Financial Results on 9 Mar..
AQ
03/03MITHRA PHARMACEUTICALS S A : and Farmitalia Announce Commercial Launch of Myring..
AQ
10/02MITHRA PHARMACEUTICALS S A : - Estelle Study Results Published in Leading Peer-R..
AQ
09/02MITHRA PHARMACEUTICALS S A : Estelleģ Study Results Published in Leading Peer-Re..
PU
05/02MITHRA PHARMACEUTICALS S A : - The Board of Directors appoints Leon Van Rompay a..
AQ
22/01MITHRA PHARMACEUTICALS S A : - Nomination of Christophe Marechal as interim CEO
AQ
21/01MITHRA PHARMACEUTICALS S A : Nomination of Christophe Maréchal as interim CEO
PU
12/01MITHRA PHARMACEUTICALS S A : Announces 2021 Financial Calendar
PU
2020MITHRA PHARMACEUTICALS S A : Richter and Mithra strengthen their partnership and..
AQ
2020MITHRA PHARMACEUTICALS S A : Estetrol recognized as a “New Active Substanc..
PU
2020MITHRA PHARMACEUTICALS S A : Scientific community convinced of Estetrol's potent..
PU
2020MITHRA PHARMACEUTICALS S A : launches an offering of up to EUR 150 million conve..
PU
2020MITHRA PHARMACEUTICALS S A : exclusivity on Estetrol applications extended to 20..
PU
2020MITHRA PHARMACEUTICALS S A : Announces Positive DSMB Safety Review and Continuat..
PU
2020MITHRA PHARMACEUTICALS S A : announces placement of EUR 125 million convertible ..
PU
2020MITHRA PHARMACEUTICALS S A : announces final terms of its offering of EUR 125 mi..
PU
2020MITHRA PHARMACEUTICALS S A : Richter and Mithra strengthen their partnership and..
PU
2020MITHRA PHARMACEUTICALS S A : Announces Positive DSMB Safety Review and Continuat..
AQ
2020MITHRA PHARMACEUTICALS S A : Announces Positive DSMB Safety Review and Continuat..
PU
2020MITHRA PHARMACEUTICALS S A : announces final terms of its offering of EUR 125 mi..
AQ
2020MITHRA PHARMACEUTICALS S A : announces placement of EUR 125 million convertible ..
PU
2020MITHRA PHARMACEUTICALS S A : launches an offering of up to EUR 150 million conve..
PU
2020Mithra - Scientific community convinced of Estetrol's potential for women's h..
AQ
2020MITHRA PHARMACEUTICALS S A : Scientific community convinced of Estetrol's potent..
PU
2020MITHRA PHARMACEUTICALS S A : exclusivity on Estetrol applications extended to 20..
AQ
2020MITHRA PHARMACEUTICALS S A : exclusivity on Estetrol applications extended to 20..
PU
2020MITHRA PHARMACEUTICALS S A : Estetrol recognized as a 'New Active Substance' by ..
AQ
2020MITHRA PHARMACEUTICALS S A : SA - Creation of a New Share Option Plan in Replace..
AQ
2020MITHRA PHARMACEUTICALS S A : - E4/DRSP, a Novel Combined Oral Contraceptive, sub..
AQ
2020MITHRA PHARMACEUTICALS S A : Signs License and Supply Agreement for Commercializ..
AQ
2020MITHRA PHARMACEUTICALS S A : Signs License and Supply Agreement for Commercializ..
PU
2020MITHRA PHARMACEUTICALS S A : Renews its Board of Directors to Support its Operat..
AQ
2020MITHRA PHARMACEUTICALS S A : Signs LSA for Commercialization of Estelle in North..
AQ
2020Mithra Announces FDA update
AQ
2020MITHRA PHARMACEUTICALS S A : Announces FDA update
PU
2020MITHRA PHARMACEUTICALS S A : Announces 2020 Half Year Results
AQ
2020MITHRA PHARMACEUTICALS S A : Half Year 2020 Results
PU
2020MITHRA PHARMACEUTICALS S A : Announces 2020 Half Year Results
PU
2020MITHRA PHARMACEUTICALS S A : to Host Webcast for Half Year Financial Results on ..
PU
2020MITHRA PHARMACEUTICALS S A : EGM Approves Warrant Plan for Share Lending Shareho..
AQ
2020MITHRA PHARMACEUTICALS S A : - Publication of a Transparency Notification Receiv..
AQ
2020MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received..
PU
2020MITHRA PHARMACEUTICALS S A : Announces Commercial Launch of Myring in the Nether..
AQ
2020MITHRA PHARMACEUTICALS S A : - Notice of Extraordinary Shareholders Meeting on 7..
AQ
2020MITHRA PHARMACEUTICALS S A : Notice of Extraordinary Shareholders' Meeting on 7t..
PU
2020MITHRA PHARMACEUTICALS S A : Information relative au nombre total de droits de v..
PU
2020MITHRA PHARMACEUTICALS S A : Announces Shelf Life Extension for Myring™ to..
PU
2020MITHRA PHARMACEUTICALS S A : Announces Commercial Launch of Tibelia in Canada
AQ
1  2  3  4Volgende
Volgende evenement op MITHRA PHARMACEUTICALS S.A.
Komende gebeurtenissen in de sector